Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-92 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-645 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-06 |
filingDate |
1986-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_111b88ac4b20a00ba1110df78ed78de7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3164372289c8fe85298ead1647885606 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af727979c1e5d86cd123c8a26049c820 |
publicationDate |
1987-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0212293-A2 |
titleOfInvention |
Process for the microbial hydroxylation of forskolin and derivatives by Neurospora crassa |
abstract |
The present invention relates to forskolin analogs and derivatives and to a method for their production by means of microbial conversions by microorganisms of the Neurospora crassa strain.n n n The compounds produced according to the invention have diverse pharmacological effects and can therefore be used as medicaments. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5247097-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0257631-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0257631-B1 |
priorityDate |
1985-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |